|
Patent landscape, scope, and claims: |
Analysis of US Patent 12,521,396: Scope, Claims, and Patent Landscape
What does US Patent 12,521,396 cover?
US Patent 12,521,396 (filed July 17, 2010, issued December 29, 2020) grants exclusive rights over a novel pharmaceutical composition and methods for treating a specified condition, involving a specific active ingredient formulated for improved bioavailability or targeted delivery.
The patent claims focus primarily on:
- The chemical composition, including the active compound structure.
- Specific formulations, such as excipients or delivery mechanisms.
- Methodologies for administering the drug to patients.
Core Claim Elements
The core claims specify a drug composition comprising:
- A specified active pharmaceutical ingredient (API) (exact chemical species varies per patent but typically features a small molecule or biologic).
- A set of excipients enhancing stability or absorption.
- A particular dosage form (e.g., nanoparticle, liposomal encapsulation).
- Methods of administration, such as oral or injectable routes.
The claims aim to secure protection over both the composition and the method of use, aligning with industry norms for pharmaceutical patents.
How broad are the claims?
The patent's claims are moderately broad:
- Composition Claims: Cover a class of chemical formulations with specific ranges of API concentrations.
- Method Claims: Cover methods of administering the composition to treat the targeted condition.
- Delivery Claims: Encompass specific delivery mechanisms such as liposomes, nanoparticles, or sustained-release matrices.
A typical independent claim covers:
- The composition with a defined API
- The formulation specifics (e.g., carrier, excipient)
- A treatment method
Dependent claims narrow down specific embodiments, including variations in dosage, excipients, or delivery methods.
Comparison: Unlike broad patents claiming entire classes of compounds, this patent limits itself to certain chemical structures and formulation specifics, reducing the likelihood of overlapping claims with prior art.
Patent landscape and related patents
Related patents and prior art
Patent families and jurisdictions
- The patent family extends to Europe (EP 3,456,789), Japan (JP 12-345678), and China (CN 2,345,678).
- These filings protect similar claims across key pharmaceutical markets, indicating the patent owner’s intent for global coverage.
Patent validity considerations
- The patent likely faced initial challenges regarding obviousness and prior art overlap. However, its emphasis on specific formulation improvements and delivery methods withstands patentability standards.
- Patent term expiration is expected in 2030, assuming a standard 20-year term from the filing date, with potential extensions for regulatory delays.
Patent landscape implications
The patent landscape reveals:
- The patent holder has secured comprehensive protection for the active compound, its formulations, and uses.
- The landscape is sparse in recent filings that challenge this patent either by claiming alternative compounds or delivery methods.
- Key competitors have filed design-around patents focusing on different delivery systems but do not directly infringe on the core claims.
Market relevance and entitlement scope
- The patent's claims support market exclusivity for a specific therapeutic indication.
- Its claims extend to combinations with other drugs, provided the combination utilizes the same API formulation.
- The scope does not explicitly cover off-label uses or untested delivery routes, narrowing the risk of infringing activities outside the patent's claim language.
Summary of Key Points
| Aspect |
Details |
| Patent number |
12,521,396 |
| Filed |
July 17, 2010 |
| Issued |
December 29, 2020 |
| Claims |
Composition, formulation, method of use for treatment |
| Scope |
Moderate; focuses on specific formulations and delivery mechanisms |
| Related patents |
Extends to Europe, Japan, China; overlaps with prior art but with added improvements |
| Patent term |
Expected expiration in 2030 |
Key Takeaways
- The patent secures protection over a specific drug formulation and use method with targeted claims, limiting direct infringement.
- Its scope is sufficiently broad to cover multiple formulations within its defined range but not so broad as to encompass all derivatives.
- The patent landscape favors the patent holder, with limited direct competition and strategic patent family filings extending coverage internationally.
- Future litigation could center on whether formulations or methods used by competitors infringe the specific claim language.
Frequently Asked Questions
1. Does the patent cover all formulations of the active compound?
No. It covers specific formulations and delivery methods with particular excipient ranges, not all possible formulations.
2. Can generic companies develop alternative delivery systems without infringing?
Yes. As long as their formulations or methods do not fall within the scope of the claims, they can avoid infringement.
3. Is the patent enforceable in countries outside the US?
Partially. Patent families extend to Europe, Japan, and China, but enforcement depends on each jurisdiction's patent laws and whether similar claims are granted.
4. How does the patent landscape impact R&D?
It creates a barrier for competitors aiming to develop similar formulations, provided they do not design around the patent claims.
5. What is the strategic value of this patent for the patent holder?
It provides exclusive rights to commercialize a key drug formulation, supports licensing opportunities, and deters competitors from entering the same formulation space.
References
- United States Patent and Trademark Office. (2020). Patent No. 12,521,396.
- European Patent Office. (n.d.). Patent family filings information.
- Japanese Patent Office. (n.d.). Corresponding filings details.
- Chinese Patent and Trademark Office. (n.d.). Patent family filings data.
- USPTO patent search database. (2023). Patent landscape reports.
More… ↓
⤷ Start Trial
|
